NightHawk Biosciences Competitors and Similar CompaniesClear all
NightHawk Biosciences's competitors and similar companies include Aeglea and Odyssey Therapeutics.
 NightHawk Biosciences NightHawk Biosciences (formerly known as Heat Biologics) is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. | |
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 2021 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Durham, US HQ Morrisville, US | Locations Austin, US HQ | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US |
Employees | Employees 3058% increase | Employees 65117% increase | Employees 1481% decrease |
Valuation ($) | Valuation ($) 14.9 m | Valuation ($) 48.6 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($34.3m) (FY, 2024) | Net income ($155.2m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Aeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View company